Tumor Necrosis Factor Receptor-associated Factor (TRAF) 5 and TRAF2 Are Involved in CD30-mediated NFκB Activation-Reference-Cited by-同舟云学术

Tumor Necrosis Factor Receptor-associated Factor (TRAF) 5 and TRAF2 Are Involved in CD30-mediated NFκB Activation

Published:1997-01 Issue:4 Volume:272 Page:2042-2045
ISSN:0021-9258
Container-title:Journal of Biological Chemistry
language:en
Short-container-title:Journal of Biological Chemistry

Author:

Aizawa Shigemi,Nakano Hiroyasu,Ishida Takaomi,Horie Ryouichi,Nagai Masae,Ito Kinji,Yagita Hideo,Okumura Ko,Inoue Junichiro,Watanabe Toshiki

Publisher

Elsevier BV

Subject

Cell Biology,Molecular Biology,Biochemistry

Reference28 articles.

1. CD30 (Ki-1) molecule: a new cytokine receptor of the tumor necrosis factor receptor superfamily as a tool for diagnosis and immunotherapy

2. Molecular cloning and expression of a new member of the nerve growth factor receptor family that is characteristic for Hodgkin's disease

3. The TNF receptor superfamily of cellular and viral proteins: Activation, costimulation, and death

4. Unraveling Function in the TNF Ligand and Receptor Families

Cited by 157 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Molecular mechanism of co-stimulatory domains in promoting CAR-T cell anti-tumor efficacy;Biochemical Pharmacology;2024-09

2. Targeting CD 30 in Lymphoid Neoplasms;Precision Cancer Therapies vol 2 ‐ Immunologic Approaches for the Treatment of Lymphoid Malignancies ‐ From Concept to Practice;2024-02-21

3. CD30 protects EBV-positive diffuse large B-cell lymphoma cells against mitochondrial dysfunction through BNIP3-mediated mitophagy;Cancer Letters;2024-02

4. Diffuse Large B-Cell Lymphoma with CD30-Positive Easily Misdiagnosed as ALCL: 1 Case Report and Literature Review;Advances in Clinical Medicine;2024

5. Mechanism of action and therapeutic targeting of CD30 molecule in lymphomas;Frontiers in Oncology;2023-12-22